A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 5, 2001, Pages 613-624

  Janssen, M J R ^a   Van Oijen, A H A M ^a   Verbeek, A L M ^a   Jansen, J B M J ^a   De Boer, W A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; LANSOPRAZOLE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; PEPTIC ULCER; PRIORITY JOURNAL; SIDE EFFECT;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; CLARITHROMYCIN; DRUG COSTS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NITROIMIDAZOLES; PATIENT CARE PLANNING; PENICILLINS; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; RANITIDINE; TREATMENT OUTCOME;

EID: 0035029118     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00974.x     Document Type: Article

References (105)

1. Cure of duodenal ulcer associated with eradication of Helicobacter pylori
2. Helicobacter pylori infection and duodenal ulcer disease
3. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection
4. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review
5. Randomized double-blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection
6. Helicobacter pylori eradication reduces the possibility of rebleeding in peptic ulcer disease
7. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: A long term follow-up study
8. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
9. The importance of clarithromycin dose in the management of Helicobacter pylori infection: A meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole
10. Ranitidine bismuth citrate: A novel anti-ulcer agent with different physicochemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture
11. Review article: Treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based tripletherapies
12. Evaluation of treatment regimens to cure Helicobacter pylori infection - A meta-analysis
13. Review article: One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori
14. Effect of pre-treatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy. A meta-analytical approach
15. A systematic review of Helicobacter pylori eradication therapy - The impact of antimicrobial resistance on eradication rates
16. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: A meta-analysis
17. Ranitidine bismuth citrate with clarithromycin given alone or with metronidazole for 7 days effectively eradicates Helicobacter pylori
18. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection
19. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States
20. Bias in meta-analysis detected by a simple, graphical test
21. Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: A single center comparison of four 14-day schedules
22. Omeprazole-based antimicrobial therapies: Results in 198 Helicobacter pylori-positive patients
23. Erosive duodenitis: Prevalence of Helicobacter pylori infection and response to eradication therapy with omeprazole plus two antibiotics
24. Unhealed duodenal ulcers despite Helicobacter pylori eradication
25. Ulcusheilung durch helicobacter-pylori-eradikation: Genügt eine woche therapie?
26. Helicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules
27. Effectiveness of H. pylori treatment regimes in clinical practice: A community-based outcomes study
28. What is the relevance of the randomised controlled clinical trial in H. pylori eradication to routine clinical practice?
29. Efficacy of repeat treatments after initial failure of Helicobacter pylori eradication therapy
30. Evaluation of different treatment schedules in childhood Helicobacter pylori gastritis: A 10 year experience
31. Triple therapy with omeprazole and two antibiotics in children with Helicobacter pylori gastritis
32. Comparison of three alternative strategies for Helicobacter pylori eradication in patients with chronic gastritis
33. The eradication of Helicobacter pylori in practice: An audit of three years clinical experience with peptic ulcer patients
34. Different Helicobacter pylori eradication rates between non-ulcer dyspepsia and peptic ulcer patients
35. Reinfekcja helicobacter pylori u chorych z wrzodem dwunastnicy pro przebytej skutecznej eradykacji
36. Comparison of 4 triple therapies combining omeprazole and 2 antibiotics for the eradication of Helicobacter pylori (H. pylori). Interest of bacampicilline and azithromycin
37. A multicenter study of lansoprazole combined with antibiotics to eradicate Helicobacter pylori infection in the patients with duodenal ulcer
38. Comparison of multidrug regimens for eradication of Helicobacter pylori
39. Short course treatment to eradicate H. pylori in 246 patients with peptic ulcer disease
40. Comparison of two one-week triple therapy regimens for Helicobacter pylori eradication in a public hospital of Hong Kong
41. Assessment of Helicobacter pylori eradication in the limited availability: Is it possible?
42. Role of metronidazole and clarithromycin resistance on the outcome of omeprazole-based triple therapies for H. pylori eradication
43. One-week triple therapy for eradication of Helicobacter pylori (with ranitidine bismuth citrate, clarithromycin [250 or 500 mg] and amoxicillin or tinidazole)
44. Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: Results of a multicentre study in South-East Asia
45. Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population
46. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or susceptible Helicobacter pylori strains
47. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients
48. The GU-MACH study: The effect of 1-week omeprazole triple therapy on Helicobacter pylori infections in patients with gastric ulcer
49. Eradication of Helicobacter pylori in routine clinical practice: Doubts and uncertainties
50. The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori
51. The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen
52. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice
53. The DU-MACH study: Eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy
54. Helicobacter pylori y hemorragia digestiva por ulcera duodenal: Prevalencia de la infeccion, eficacia de tres terapias triples y papel de la erradicacion en la prevencion de la recidiva hemorragica
55. The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
56. Omeprazol más dos antibióticos para la erradición de H. pylori. ?son suficientes cinco días de tratiamento?
57. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration
58. Relationships between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection
59. Comparison of two 1-week low-dose omeprazole triple therapies - Optimal treatment for Helicobacter pylori infection?
60. One week triple therapy for Helicobacter pylori: A multicentre comparative study
61. A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori
62. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study
63. Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection
64. Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus
65. Efficacy of lansoprazole in association with clarithromicyn and metronidazole or amoxycillin for Helicobacter pylori eradication
66. Comparison of three 7 days pantoprazole based Helicobacter pylori eradication schemes in a mexican population with highly metronidazole resistant Hp strains
67. Low-dose, one-week triple therapy for Hp: A randomized study
68. Randomised study comparing two seven days triple therapies with lansoprazole and low dose of clarithromycin plus amoxicillin or tinidazole for Helicobacter pylori eradication
69. Comparison of two treatment strategies for the eradication of H. pylori utilizing a screening antibody serum blot test and confirmatory c 14 breath test
70. Pantoprazole plus clarythromycin and metronidazole versus pantoprazole plus clarythromycin and amoxycillin for therapy of H. pylori infection
71. High-dosage omeprazole-based triple therapy for the eradication of H. pylori infection: A randomised trial
72. A single-blind monocentric study of four treatments for H. pylori eradication: An interim report
73. Randomized study comparing three different triple regimens containing clarithromycin for H. pylori (Hp) eradication in patients with duodenal ulcer
74. One-week b.i.d. therapy for H. pylori: A randomised comparison of three strategies on clinical outcome and side-effects
75. A prospective, randomised, controlled, investigator-blind, single-centre trial comparing two one-week omeprazole triple therapies for healing peptic ulcer and eradication of Helicobacter pylori infection
76. Comparison of two one-week triple therapies with a low dose of lansoprazole and two low dose antibiotics in Helicobacter pylori eradication: A French study
77. Failure of standard triple therapies for H. pylori eradication in dyspeptic outpatients
78. Pantoprazole in eradication of peptic ulcer (H. pylori) positive patients: A multicentre randomised prospective study by GISU (interdisciplinary ulcer study group)
79. Comparison of metronidazole or amoxycillin based 1-week low dose triple therapy in the treatment of active duodenal ulcer: Can pre-treatment urea breath test values predict the outcome?
80. Is the efficacy of H. pylori therapy similar in Japanese and Swedish patients? A single blind randomised head-to-head comparison
81. Efficacy of one week pantoprazole containing triple therapies for eradication of Helicobacter pylori
82. Seven days of omeprazole and clarithromycin with either amoxicillin or metronidazole for Helicobacter pylori eradication - Results of a single-blinded randomised trial in the community
83. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection
84. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: The RBC-MACH study
85. One-week therapy for Helicobacter pylori eradication: Ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin
86. Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate
87. Ranitidine bismuth citrate with low-dose clarythromycin and metronidazole for one week gives high rates of H. pylori eradication
88. Two open-label efficacy trials of ranitidine bismuth citrate (RBC) in combination with clarithromycin (C) and amoxicillin (A) or metronidazole (M) for Helicobacter pylori (Hp) eradication
89. Ranitidine bismuth citrate (Pylorid) with low dose clarythromycin and metronidazole twice daily for one week gives high rates of H. pylori eradication
90. Cost and efficacy of 7-day triple therapies for Helicobacter pylori eradication: PPI-based vs RBC-based regimens
91. Meta-analysis: When and how
92. Meta-analysis: Principles and procedures
93. Meta-analysis: Bias in location and selection of studies
94. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia
95. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection
96. The impact of antibiotic resistance on the efficacy of three 7-day triple regimens against H. pylori infection
97. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori
98. Antibiotic resistance in Helicobacter pylori: Implications for therapy
99. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori
100. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication
101. Helicobacter pylori antimicrobial resistance in the United States: Preliminary results of a 9-center study
102. Treatment of Helicobacter pylori infection
103. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance
104. Maastricht consensus report regimen for second line treatment of Helicobacter pylori infection: How does it perform in practice?